By Jeff Zalesin ( October 29, 2015, 4:57 PM EDT) -- Venture capital-backed heart disease treatment developer MyoKardia raised $54.4 million Wednesday in an initial public offering priced below the expected range, becoming the latest in a series of health-related new issuers to take discounts as tough market conditions take their toll on the life sciences sector....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.